Home
ANNX
ANNX News

Latest Annexon Inc. (ANNX) News on June 3, 2025

Annexon Biosciences to Present at the Jefferies Global Healthcare Conference

GlobeNewswire

4 days ago

Annexon Biosciences to Present at the Jefferies Global Healthcare Conference

Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting

GlobeNewswire

14 days ago

Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

17 days ago

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Annexon Reports First Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones

GlobeNewswire

22 days ago

Annexon Reports First Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones

Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting

GlobeNewswire

24 days ago

Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting

Annexon to Present on the Neuroprotective Effects of ANX007 at the 2025 ARVO Annual Meeting and the Retina World Congress

GlobeNewswire

a month ago

Annexon to Present on the Neuroprotective Effects of ANX007 at the 2025 ARVO Annual Meeting and the Retina World Congress

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 months ago

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Why Annexon Inc. (ANNX) Went Down On Thursday?

Insider Monkey

2 months ago

Why Annexon Inc. (ANNX) Went Down On Thursday?

Annexon's Investigational Drug Shows Rapid Recovery And Durable Benefit In Rare Neurological Disorder

Benzinga

2 months ago

Annexon's Investigational Drug Shows Rapid Recovery And Durable Benefit In Rare Neurological Disorder

MT Newswires

2 months ago

Annexon Cites 'Durable Benefit' of Tanruprubart in Guillain-Barre Syndrome Trial

Annexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual Meeting

GlobeNewswire

2 months ago

Annexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual Meeting

Annexon Highlights Leadership in Advancing Clinical Research and Education for Guillain-Barré Syndrome (GBS) at American Academy of Neurology (AAN) 2025 Annual Meeting

GlobeNewswire

2 months ago

Annexon Highlights Leadership in Advancing Clinical Research and Education for Guillain-Barré Syndrome (GBS) at American Academy of Neurology (AAN) 2025 Annual Meeting

Here's Why We're Not Too Worried About Annexon's (NASDAQ:ANNX) Cash Burn Situation

Simply Wall St.

2 months ago

Here's Why We're Not Too Worried About Annexon's (NASDAQ:ANNX) Cash Burn Situation

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

3 months ago

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Wells Fargo Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks

TipRanks

3 months ago

Wells Fargo Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks

Annexon Reports Fourth Quarter and Year-End 2024 Financial Results, Portfolio Progress and Key Anticipated Milestones

GlobeNewswire

3 months ago

Annexon Reports Fourth Quarter and Year-End 2024 Financial Results, Portfolio Progress and Key Anticipated Milestones

Annexon Biosciences to Present at the TD Cowen 45th Annual Health Care Conference

GlobeNewswire

3 months ago

Annexon Biosciences to Present at the TD Cowen 45th Annual Health Care Conference

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

4 months ago

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Annexon Announces Presentations Highlighting ANX007 Functional and Structural Differentiation in Geographic Atrophy at the Macula Society 48th Annual Meeting

GlobeNewswire

4 months ago

Annexon Announces Presentations Highlighting ANX007 Functional and Structural Differentiation in Geographic Atrophy at the Macula Society 48th Annual Meeting

Annexon Provides 2025 Outlook with Strong Momentum Accelerating into Breakthrough Year

GlobeNewswire

5 months ago

Annexon Provides 2025 Outlook with Strong Momentum Accelerating into Breakthrough Year

Annexon Expands Board of Directors with Appointment of Commercial Executive William “BJ” Jones

GlobeNewswire

5 months ago

Annexon Expands Board of Directors with Appointment of Commercial Executive William “BJ” Jones

Annexon Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

5 months ago

Annexon Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS)

GlobeNewswire

6 months ago

Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS)

Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in Geographic Atrophy at the Floretina-ICOOR 2024 Meeting

GlobeNewswire

6 months ago

Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in Geographic Atrophy at the Floretina-ICOOR 2024 Meeting

The Dodgers’ World Series run brought attention to a rare disease. Annexon is stepping up to the plate.

Pharma Voice

6 months ago

The Dodgers’ World Series run brought attention to a rare disease. Annexon is stepping up to the plate.

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

7 months ago

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Annexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones

GlobeNewswire

7 months ago

Annexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones

Annexon Biosciences to Present at the Jefferies London Healthcare Conference

GlobeNewswire

7 months ago

Annexon Biosciences to Present at the Jefferies London Healthcare Conference

Annexon Presents Phase 2 Vision Preservation Data with ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting

GlobeNewswire

7 months ago

Annexon Presents Phase 2 Vision Preservation Data with ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting

We're Hopeful That Annexon (NASDAQ:ANNX) Will Use Its Cash Wisely

Simply Wall St.

7 months ago

We're Hopeful That Annexon (NASDAQ:ANNX) Will Use Its Cash Wisely

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

8 months ago

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Annexon to Present New Phase 2 ARCHER Data for ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting

GlobeNewswire

8 months ago

Annexon to Present New Phase 2 ARCHER Data for ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

9 months ago

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in GA at the Retina Society 57th Annual Meeting and 24th Euretina Congress

GlobeNewswire

9 months ago

Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in GA at the Retina Society 57th Annual Meeting and 24th Euretina Congress

Annexon Expands Senior Leadership in Commercial, Medical Affairs and Health Economics to Advance Global Late-Stage Neuroinflammatory-Targeted Portfolio

GlobeNewswire

9 months ago

Annexon Expands Senior Leadership in Commercial, Medical Affairs and Health Economics to Advance Global Late-Stage Neuroinflammatory-Targeted Portfolio

Annexon Biosciences to Participate in Upcoming September Investor Conferences

GlobeNewswire

9 months ago

Annexon Biosciences to Participate in Upcoming September Investor Conferences

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

10 months ago

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

10 months ago

Annexon Files Registration Statement on Behalf of Selling Shareholders

Annexon Reports Second Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones

GlobeNewswire

10 months ago

Annexon Reports Second Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones

Is Arbutus Biopharma (ABUS) Outperforming Other Medical Stocks This Year?

Zacks

10 months ago

Is Arbutus Biopharma (ABUS) Outperforming Other Medical Stocks This Year?

Annexon Insider Ups Holding During Year

Simply Wall St.

10 months ago

Annexon Insider Ups Holding During Year

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Is CareCloud (CCLD) Outperforming Other Medical Stocks This Year?

Zacks

a year ago

Is CareCloud (CCLD) Outperforming Other Medical Stocks This Year?

Annexon to Present Additional Phase 2 Data Showing Preservation of Visual Function and Structure by ANX007 in Geographic Atrophy at the 42nd ASRS Annual Scientific Meeting

GlobeNewswire

a year ago

Annexon to Present Additional Phase 2 Data Showing Preservation of Visual Function and Structure by ANX007 in Geographic Atrophy at the 42nd ASRS Annual Scientific Meeting

Are Analysts Bullish on Annexon, Inc. (ANNX) Right Now?

Insider Monkey

a year ago

Are Analysts Bullish on Annexon, Inc. (ANNX) Right Now?

Are Medical Stocks Lagging Annexon (ANNX) This Year?

Zacks

a year ago

Are Medical Stocks Lagging Annexon (ANNX) This Year?

Here's Why Annexon (ANNX) Is a Great 'Buy the Bottom' Stock Now

Zacks

a year ago

Here's Why Annexon (ANNX) Is a Great 'Buy the Bottom' Stock Now

MT Newswires

a year ago

Annexon Reports 'Positive' Results From Phase 3 Study of Guillain-Barre Syndrome

Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guillain-Barré Syndrome at the 2024 PNS Annual Meeting

GlobeNewswire

a year ago

Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guillain-Barré Syndrome at the 2024 PNS Annual Meeting

Annexon To Present Pivotal Phase 3 Data On Early And Durable Benefits With First-In-Class C1q Blocking Antibody ANX005 In Guillain-Barré Syndrome At 2024 PNS Annual Meeting

GlobeNewswire

a year ago

Annexon To Present Pivotal Phase 3 Data On Early And Durable Benefits With First-In-Class C1q Blocking Antibody ANX005 In Guillain-Barré Syndrome At 2024 PNS Annual Meeting

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Is Annexon (ANNX) Stock Outpacing Its Medical Peers This Year?

Zacks

a year ago

Is Annexon (ANNX) Stock Outpacing Its Medical Peers This Year?

MT Newswires

a year ago

Sector Update: Health Care Stocks Steady Premarket Thursday

MT Newswires

a year ago

Annexon Prices $125 Million Stock Offering

Annexon Announces Pricing of $125 Million Underwritten Public Offering

GlobeNewswire

a year ago

Annexon Announces Pricing of $125 Million Underwritten Public Offering

Annexon (ANNX) Up as Phase III Neuro Disorder Study Meets Goals

Zacks

a year ago

Annexon (ANNX) Up as Phase III Neuro Disorder Study Meets Goals

Wall Street Analysts Think Annexon (ANNX) Could Surge 133.72%: Read This Before Placing a Bet

Zacks

a year ago

Wall Street Analysts Think Annexon (ANNX) Could Surge 133.72%: Read This Before Placing a Bet

MT Newswires

a year ago

Sector Update: Health Care Stocks Steady Premarket Wednesday

Annexon’s ANX005 offers improvement in Phase III GBS trial

Clinical Trials Arena

a year ago

Annexon’s ANX005 offers improvement in Phase III GBS trial

MT Newswires

a year ago

Annexon Launches $125 Million Share Offering

Annexon Announces Proposed Public Offering of Common Stock

GlobeNewswire

a year ago

Annexon Announces Proposed Public Offering of Common Stock

Mid-Cap Firm Annexon's Nerve Disorder Candidate Shows Promise In Pivotal Late-Stage Study

Benzinga

a year ago

Mid-Cap Firm Annexon's Nerve Disorder Candidate Shows Promise In Pivotal Late-Stage Study

MT Newswires

a year ago

Sector Update: Health Care Stocks Steady Pre-Bell Tuesday

MT Newswires

a year ago

Sector Update: Health Care

MT Newswires

a year ago

Annexon Says Phase 3 Trial of Potential Guillain-Barre Syndrome Treatment Meets Primary Endpoint

MT Newswires

a year ago

Top Premarket Gainers

Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blocking Antibody ANX005 in Guillain-Barré Syndrome

GlobeNewswire

a year ago

Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blocking Antibody ANX005 in Guillain-Barré Syndrome

Annexon Biosciences to Host Conference Call and Webcast to Discuss GBS Phase 3 Data

GlobeNewswire

a year ago

Annexon Biosciences to Host Conference Call and Webcast to Discuss GBS Phase 3 Data

Annexon (ANNX) Loses -5.04% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

a year ago

Annexon (ANNX) Loses -5.04% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

We Think Annexon (NASDAQ:ANNX) Can Afford To Drive Business Growth

Simply Wall St.

a year ago

We Think Annexon (NASDAQ:ANNX) Can Afford To Drive Business Growth

Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones

GlobeNewswire

a year ago

Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones

Annexon Biosciences to Present at the Bank of America Health Care Conference

GlobeNewswire

a year ago

Annexon Biosciences to Present at the Bank of America Health Care Conference

Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual Meeting

GlobeNewswire

a year ago

Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual Meeting

Annexon (ANNX) to Report Q1 Earnings: What's in the Cards?

Zacks

a year ago

Annexon (ANNX) to Report Q1 Earnings: What's in the Cards?

Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting

GlobeNewswire

a year ago

Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting

Down -43.02% in 4 Weeks, Here's Why You Should You Buy the Dip in Annexon (ANNX)

Zacks

a year ago

Down -43.02% in 4 Weeks, Here's Why You Should You Buy the Dip in Annexon (ANNX)

Are Medical Stocks Lagging Annexon (ANNX) This Year?

Zacks

a year ago

Are Medical Stocks Lagging Annexon (ANNX) This Year?

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Turnstone Biologics Appoints William Waddill to its Board of Directors

GlobeNewswire

a year ago

Turnstone Biologics Appoints William Waddill to its Board of Directors

10 Buy-Rated Stocks with Latest Insider Purchases

Insider Monkey

a year ago

10 Buy-Rated Stocks with Latest Insider Purchases

Annexon, Inc. (ANNX) Falls More Steeply Than Broader Market: What Investors Need to Know

Zacks

a year ago

Annexon, Inc. (ANNX) Falls More Steeply Than Broader Market: What Investors Need to Know

Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire

a year ago

Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

What Makes Annexon (ANNX) a New Buy Stock

Zacks

a year ago

What Makes Annexon (ANNX) a New Buy Stock

Wall Street Analysts Believe Annexon (ANNX) Could Rally 101.12%: Here's is How to Trade

Zacks

a year ago

Wall Street Analysts Believe Annexon (ANNX) Could Rally 101.12%: Here's is How to Trade

GuruFocus.com

a year ago

Annexon Inc (ANNX) Reports Year-End Financials, Aligns with Analyst Projections

Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones

GlobeNewswire

a year ago

Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Why Annexon (ANNX) Might Surprise This Earnings Season

Zacks

a year ago

Why Annexon (ANNX) Might Surprise This Earnings Season

J.P. Morgan Predicts up to 140% Rally for These 2 ‘Strong Buy’ Stocks

TipRanks

a year ago

J.P. Morgan Predicts up to 140% Rally for These 2 ‘Strong Buy’ Stocks

Annexon Biosciences to Present at the TD Cowen 44th Annual Health Care Conference

GlobeNewswire

a year ago

Annexon Biosciences to Present at the TD Cowen 44th Annual Health Care Conference

Annexon to Host Virtual R&D Day on Guillain-Barré Syndrome, Focusing on its Serious Unmet Need and Annexon’s Novel Therapeutic Approach

GlobeNewswire

a year ago

Annexon to Host Virtual R&D Day on Guillain-Barré Syndrome, Focusing on its Serious Unmet Need and Annexon’s Novel Therapeutic Approach

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Steven Cohen's Point72 Asset Management Acquires New Stake in Annexon Inc

GuruFocus.com

a year ago

Steven Cohen's Point72 Asset Management Acquires New Stake in Annexon Inc

Recent uptick might appease Annexon, Inc. (NASDAQ:ANNX) institutional owners after losing 18% over the past year

Simply Wall St.

a year ago

Recent uptick might appease Annexon, Inc. (NASDAQ:ANNX) institutional owners after losing 18% over the past year

Invesco Mortgage Capital (IVR) Rises Higher Than Market: Key Facts

Zacks

a year ago

Invesco Mortgage Capital (IVR) Rises Higher Than Market: Key Facts

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 01/31/2024

1 Reason to Buy Novavax Stock, and 3 (Better) Reasons to Sell

Motley Fool

a year ago

1 Reason to Buy Novavax Stock, and 3 (Better) Reasons to Sell

Girona take Liga lead back with win at Celta

AFP

a year ago

Girona take Liga lead back with win at Celta

Share on Social Networks: